The Strange Link Between Vitamin D and Pain: What Scientists Have Discovered — And What It Means for You

 

Over a billion people worldwide may be quietly deficient in the one vitamin now emerging as a key player in how the body feels, processes, and amplifies pain. Here is what the latest research really says — and why it matters far beyond your bones.

For decades, vitamin D carried a simple, reassuring reputation. It was the sunshine vitamin — important for bones, friendly to your immune system, and something your doctor might recommend alongside calcium. Nobody thought of it as something that could stand between you and a life lived in pain. But over the past several years, a growing and genuinely strange body of scientific evidence has begun to reframe vitamin D in a way that surprises even veteran researchers: this humble nutrient appears to be deeply entangled with how your nervous system experiences, amplifies, and sometimes sustains pain.

The connection is not clean or straightforward, which is precisely what makes it scientifically fascinating and clinically important. It is not a simple story of "take vitamin D, feel less pain." It is stranger, more nuanced, and far more interesting than that. People with chronic pain are far more likely to be vitamin D deficient. People with severe deficiency are statistically more likely to report widespread pain. And in certain specific conditions — from menstrual pain to fibromyalgia to painful diabetic neuropathy — supplementation appears to produce measurable relief. Yet in large, well-controlled trials involving thousands of people who already have adequate vitamin D, supplementation does almost nothing at all. The picture that emerges from the research is one of a threshold effect, a biological tipping point, below which vitamin D's absence may quietly magnify suffering.

This article examines everything science currently knows about that link — the biology, the clinical studies, the statistics, the unanswered questions, and what any person living with chronic or recurrent pain should reasonably consider.

>1B

People worldwide estimated to have vitamin D deficiency or insufficiency^[1]

13%

More likely to have chronic pain if vitamin D is below 50 nmol/L, per UK Biobank study of 349,221 adults^[2]

93%

Of patients with persistent non-specific musculoskeletal pain found to be vitamin D deficient in one landmark study^[3]

81.7%

Of chronic myofascial pain patients found to have insufficient or deficient vitamin D levels^[4]

The Biology: Why Would a Vitamin Have Anything to Do With Pain?

To understand the vitamin D-pain connection, you need to know something surprising about where vitamin D receptors actually live in your body. Most people know the vitamin works in the gut and the kidneys, helping absorb calcium. What most people do not know is that vitamin D receptors (VDRs) are also expressed in neurons in the skin, dorsal root ganglia, spinal cord, and brain — the very structures that detect, transmit, and process pain signals.^[5] This is not a minor footnote. It is a biological bombshell that has redirected an entire field of research.

Your experience of pain begins when specialized nerve endings called nociceptors detect something potentially harmful — heat, pressure, chemicals — and fire an electrical signal. That signal travels through nerve fibers into your dorsal root ganglia and up through the spinal cord to your brain, where it is decoded as pain. This entire cascade involves a series of molecular gates, receptors, and chemical messengers. And vitamin D, through its receptor expressed at key points along this pathway, has now been found to influence several of them simultaneously.

One of the most studied mechanisms involves a receptor called TRPV1 — short for Transient Receptor Potential Vanilloid 1 — which functions as a sensor for heat and inflammatory pain. Research published in Frontiers in Immunology found that vitamin D acts on TRPV1 to inhibit pain signal conduction, effectively putting a partial brake on the channel through which heat and chemical pain signals travel.^[5] When vitamin D is absent, that brake loosens.

Vitamin D also interacts with Nerve Growth Factor (NGF), a protein that regulates the survival and function of pain-sensing neurons. People deficient in vitamin D show decreased NGF expression, and vitamin D supplementation has been demonstrated to increase NGF synthesis in human cells — a finding with significant implications for conditions like diabetic neuropathy, where nerve cell deterioration is a core feature of the disease.^[6] Beyond this, vitamin D modulates the activity of glial cells in the spinal cord — the support cells that, when chronically activated, drive the phenomenon known as central sensitization, in which the nervous system becomes hyperresponsive and amplifies pain far beyond what the original injury would justify.

"Vitamin D/VDR plays a role in pain-sensing through modulating key pain-genes. Some of these pain-genes are common to both nociception and visceral nociception, including TRPV1, Toll-like receptor, and trophic factors such as NGF and BDNF."

— Frontiers in Immunology, Pain Signaling Pathways Review, 2020 ^[5]

There is also an anti-inflammatory angle. Vitamin D receptors are expressed on immune cells including monocytes, macrophages, and T lymphocytes. When vitamin D binds these receptors, it suppresses the production of pro-inflammatory cytokines — chemical messengers that drive inflammation and, with it, inflammatory pain. A body chronically short on vitamin D is, in effect, running with a loosened inflammatory thermostat, allowing low-grade chronic inflammation to smolder longer and burn hotter. For anyone living with a condition where inflammation is a primary driver of pain — rheumatoid arthritis, inflammatory back pain, or even post-injury pain — this matters enormously.

Perhaps most intriguing of all is a 2024 study published in the journal Pain which identified a completely new mechanism: vitamin D3 was found to suppress a cell death process called ferroptosis in spinal cord neurons following nerve injury, specifically preserving GABAergic interneurons — the neurons responsible for inhibiting pain signals.^[7] Without sufficient vitamin D, these inhibitory neurons may be lost or impaired, leaving the pain amplification system running without adequate brakes.

The Epidemiology: How Strong Is the Association?

If vitamin D genuinely plays a role in pain biology, you would expect to see population-wide patterns linking deficiency to pain. And that is precisely what researchers have found — though with important caveats about the direction of causality.

The largest and most rigorous study to date on this question used data from the UK Biobank, analyzing 349,221 adults — one of the biggest datasets ever deployed for this purpose. Published in The Journal of Pain in 2024, it found that people with vitamin D levels below 50 nmol/L reported significantly more chronic musculoskeletal pain than those with higher levels. The effect persisted even after the researchers adjusted for confounders including age, sex, obesity, physical activity, and socioeconomic factors. Crucially, severe vitamin D deficiency was independently associated with chronic widespread pain.^[2]

This was not an isolated finding. Studies on chronic widespread pain have reported vitamin D deficiency prevalence rates ranging from 23% to 93% in affected patients — a remarkably wide range, but one that consistently points in the same direction.^[1] In one particularly striking cross-sectional study, Plotnikoff and Quigley found vitamin D deficiency in 93% of 150 patients with persistent non-specific musculoskeletal pain — approximately double the rate seen in the general population at the same latitude.

A 2024 Mendelian randomization analysis published in Translational Psychiatry (a method that uses genetic variants to infer causality, reducing the problem of reverse causation) found evidence for a non-linear relationship between vitamin D levels and chronic pain outcomes, suggesting that benefits are concentrated among those who are genuinely deficient — not those who are already vitamin D sufficient.^[8]

Study / Source	Population	Key Finding	Year
UK Biobank (Xie et al., J Pain)	349,221 UK adults	Vitamin D <50 nmol/L → 13% higher odds of chronic musculoskeletal pain	2024
Fibromyalgia Meta-Analysis (Nutrients)	687 participants, 11 RCTs	Vitamin D supplementation significantly reduced pain (SMD = −0.85)	2025
Dysmenorrhea Meta-Analysis (Nutrients)	695 participants, 8 RCTs	Vitamin D substantially reduced menstrual pain (SMD = −1.404)	2023
Painful Diabetic Neuropathy Meta-Analysis	320 patients, 4 RCTs	Significant short-term pain reduction (SMD = −0.85; ~11 points on pain scales)	2025
VITAL Trial Ancillary Study (Harvard)	25,871 US adults	No significant effect on pain in generally vitamin D–sufficient population	2024
Chronic Myofascial Pain Study (PMC)	120 patients	81.7% had insufficient or deficient vitamin D; deficiency linked to <15 min daily sun	2023

Condition by Condition: Where the Evidence Is Strongest

Fibromyalgia

Fibromyalgia — a condition defined by widespread musculoskeletal pain, fatigue, and heightened pain sensitivity — has long frustrated researchers because its biological roots remain murky. But the vitamin D connection here is increasingly compelling. A comprehensive systematic review and meta-analysis published in Nutrients in 2025, which followed PRISMA guidelines and screened 2,776 articles before including 7 in the review, found that vitamin D supplementation significantly reduced pain levels in fibromyalgia patients compared to controls, with a standardized mean difference of −0.85 on both the Numeric Rating Scale and the Fibromyalgia Impact Questionnaire.^[9] An effect of that magnitude is clinically meaningful — equivalent to moving from severe pain to moderate pain on standard scales.

The proposed mechanism involves vitamin D's role in modulating NMDA receptors — the molecular gates implicated in central sensitization, the process by which fibromyalgia brains become hypersensitive to normal stimuli. Research suggests that vitamin D administration reduces expression of NMDA receptor subunits, potentially quieting the amplification loop that makes fibromyalgia so difficult to treat.

Menstrual Pain (Dysmenorrhea)

One of the clearest and most actionable findings in the vitamin D–pain literature concerns menstrual pain. A meta-analysis published in Nutrients covering 8 randomized controlled trials and 695 participants found that vitamin D supplementation substantially reduced pain in women with primary dysmenorrhea, with a standardized mean difference of −1.404 — a large effect by clinical standards.^[10] A 2024 review of 11 studies involving 687 participants confirmed this, showing that supplementation significantly reduced both pain intensity and the need for rescue analgesics such as ibuprofen.

The mechanism is rooted in prostaglandin biology. Prostaglandins are hormone-like chemicals that trigger uterine contractions and inflammation during menstruation, and they are the primary driver of primary dysmenorrhea. Vitamin D is known to suppress prostaglandin synthesis, offering a plausible direct pathway from nutrient to pain relief. Critically, the effect appears specific to primary dysmenorrhea and does not extend to secondary dysmenorrhea caused by conditions like endometriosis — an important clinical distinction for patients and practitioners alike.

Neuropathic Pain and Diabetic Neuropathy

Diabetic peripheral neuropathy — nerve damage caused by sustained high blood sugar — affects an estimated 50% of people with diabetes and produces burning, shooting, or stabbing pain that is notoriously difficult to treat. The vitamin D connection here is significant. A 2025 systematic review and meta-analysis of randomized controlled trials found that vitamin D supplementation produced a significant short-term reduction in pain compared to placebo, with a pooled standardized mean difference of −0.85 — equivalent to approximately 11 points on common pain scales.^[11]

The biology is again instructive. Vitamin D increases Nerve Growth Factor synthesis, which supports the survival and repair of peripheral nerve cells. It also has neuroprotective effects including axonal survival, suppression of neuroinflammation, and improvements in sensory neural response — all functions directly relevant to the nerve deterioration that defines diabetic neuropathy. A study investigating diabetic neuropathy specifically found lower serum vitamin D in affected patients than in those without the condition, and noted that deficiency may promote the disease by triggering both hyperglycemia and inflammation simultaneously.

Migraine and Headache

The migraine-vitamin D connection is emerging but still developing. A 2025 population-based analysis published in PLOS ONE — drawing on data from 9,142 participants in the US National Health and Nutrition Examination Survey (NHANES) — examined the association between serum vitamin D levels and severe headache or migraine.^[12] While the evidence here is more mixed than in the domains above, vitamin D's role in regulating serotonin synthesis, modulating inflammation, and influencing magnesium metabolism (all implicated in migraine pathophysiology) suggests a biologically plausible link that warrants further investigation.

Chronic Low Back Pain

Chronic low back pain is among the most common pain conditions worldwide, and its intersection with vitamin D has been studied extensively. The transition from acute to chronic back pain is a major clinical challenge — and a 2025 systematic review published in Nutrients examined exactly this question, analyzing 14 eligible research articles to explore whether vitamin D influences the shift from acute to chronic pain.^[13] The findings were nuanced: vitamin D did not directly prevent the transition to chronicity, but it did appear to reduce pain intensity in patients at risk — a meaningful, if partial, effect.

What the Science Currently Supports

• Vitamin D deficiency is consistently associated with higher pain levels across multiple pain types and large population studies.
• In people who are genuinely deficient, correcting vitamin D levels may meaningfully reduce pain in fibromyalgia, menstrual pain, and diabetic neuropathy.
• Vitamin D receptors exist in key pain-sensing neurons, and the vitamin modulates pain signaling at multiple biological levels.
• Supplementation in people who are already vitamin D sufficient (levels above 50 nmol/L) appears to have little effect on pain.
• The relationship is not yet established as definitively causal — more large-scale, placebo-controlled trials in deficient populations are needed.

The Complication: When Vitamin D Supplementation Does Not Help

An honest account of this science requires confronting its most uncomfortable finding head-on. The VITAL trial — a massive five-year randomized, double-blind, placebo-controlled study of 25,871 US adults conducted at Harvard — tested whether daily supplementation with 2,000 IU of vitamin D reduced pain outcomes. The ancillary pain analysis, published in Pain in 2024, found no significant overall effect on pain prevalence or severity in the general study population.^[14]

At first glance, this appears to contradict everything discussed above. But the critical interpretive key is baseline vitamin D status. In the VITAL trial, 76% of participants were predicted to already have vitamin D levels above 50 nmol/L — meaning they were not deficient to begin with. Similarly, the large D-Health Trial in Australia, which gave participants a monthly dose of 60,000 IU vitamin D3 over five years, found no significant effect on pain outcomes — again, because most participants started with sufficient levels.

This pattern, emerging consistently across major trials, points to what researchers now call a threshold model of vitamin D and pain: the nutrient's pain-modulating effects are concentrated in the deficient range. Below the threshold, deficiency appears to amplify pain sensitivity. Above it, adding more vitamin D does not produce additional analgesia. This is, in many ways, more clinically useful than a simple "more is better" story — it means testing, not guessing, about who might benefit.

"The people with lower vitamin D levels were 13% more likely to have chronic pain than those with higher levels — a correlation that persisted after adjusting for age, sex, obesity, physical activity, and socioeconomic factors."

— Xie et al., The Journal of Pain, 2024 (n=349,221) ^[2]

A Global Deficiency Crisis — And Its Potential Pain Burden

The scale of vitamin D deficiency worldwide is difficult to overstate. A pooled analysis of 7.9 million participants spanning population-based studies from 2000 to 2022, published in Frontiers in Nutrition, found that deficiency is endemic across virtually every region of the world — including sun-rich countries in the tropics. Estimates suggest that between 25% and 50% of the global population, representing more than one billion people, have vitamin D deficiency or insufficiency.^[15]

In temperate regions including the United States, Canada, and Europe, the estimated overall prevalence of deficiency runs from 37% to 42%. Even in Southeast Asian countries with abundant sunlight, prevalence among workers has been reported at 22% to 33%. The main drivers are well established: inadequate sun exposure (worsened by indoor occupations, sunscreen use, and seasonal latitude), low dietary intake, obesity (which sequesters vitamin D in fat tissue), darker skin pigmentation (which reduces UV-driven synthesis), and advancing age.

What makes this relevant to pain medicine is a simple multiplication: if deficiency is genuinely a risk factor for amplified pain, and over a billion people are deficient, the potential contribution of vitamin D insufficiency to the global burden of chronic pain — currently estimated at $560–635 billion annually in the United States alone — may be substantial and largely unrecognized.

Opioids, Chronic Pain, and Vitamin D: An Overlooked Intersection

One of the most clinically urgent corners of this research involves the overlap between vitamin D and opioid therapy. A 2025 prospective study from the Toxicology Centre of Vilnius University Hospital in Lithuania examined vitamin D levels in patients with chronic pain undergoing long-term opioid prescription therapy. The study investigated the correlation between serum 25-hydroxyvitamin D concentrations and both quality of life and pain perception in 45 patients before opioid detoxification, finding a meaningful association between low vitamin D and worse pain outcomes.^[16]

This matters enormously in the context of the global opioid crisis. If vitamin D deficiency is silently worsening pain perception in patients prescribed opioids, some portion of escalating opioid doses may be addressing a nutritional deficiency rather than a purely nociceptive need. Vitamin D has also been shown to modulate opioid peptide genes — genes that code for endogenous pain-relieving molecules the body produces naturally. A deficient system may be less capable of generating its own internal pain relief.

✦ ✦ ✦

What You Should Actually Do With This Information

The evidence, taken as a whole, supports a measured and practical conclusion. Vitamin D is not a cure for chronic pain, and loading up on supplements if you are already vitamin D sufficient will likely accomplish nothing for your pain levels. But if you live with chronic or recurrent pain and have never had your vitamin D levels tested, the case for doing so is now stronger than ever.

Testing serum 25-hydroxyvitamin D (25-OHD) is straightforward, inexpensive, and widely available. The conventional threshold for deficiency is below 20 ng/mL (50 nmol/L), with insufficiency defined as 20–29.9 ng/mL. The UK Biobank study found meaningful differences in pain outcomes at the 50 nmol/L boundary. If your levels fall below this threshold, working with a healthcare provider to correct the deficiency — through supplementation, sensible sun exposure, or dietary changes — is a low-risk intervention with a plausible pain-reducing benefit in your particular situation.

The populations most likely to be deficient, and therefore most likely to benefit from correction, include older adults, people with darker skin tones, those working predominantly indoors, individuals with obesity, people living at high latitudes, and those with limited dietary sources of vitamin D (fatty fish, egg yolks, fortified foods). For women with primary dysmenorrhea in particular, the evidence for supplementation is among the strongest in this entire field.

For conditions like fibromyalgia, neuropathic pain, and back pain, the research is promising but still evolving. Larger, rigorously designed randomized controlled trials specifically recruiting vitamin D-deficient participants — rather than general populations — are urgently needed to establish definitive clinical protocols. The science is at an exciting but still provisional stage.

The Bigger Picture: Rethinking Vitamin D

What the vitamin D-pain story ultimately reveals is that nutrition and neurological function are more deeply intertwined than medicine has historically appreciated. For most of the twentieth century, vitamins were thought of as molecules that prevented specific deficiency diseases — scurvy, rickets, pellagra. The idea that a vitamin could quietly modulate the gain setting on your nervous system's pain processing circuitry, influencing whether a given stimulus registers as tolerable or excruciating, represents a fundamentally different and more sophisticated view of nutrient biology.

Vitamin D receptor expression in dorsal root ganglia, spinal cord neurons, and brain tissue is not a curiosity — it is a clue that this molecule was always meant to play a role in neural function, not just calcium homeostasis. The fact that we are only now beginning to properly map that role is a reminder of how much medicine still has to learn about the body's most basic systems.

What is already clear is that the global epidemic of vitamin D deficiency and the global epidemic of chronic pain are not entirely separate phenomena. They overlap in biology, in statistics, and — for millions of individuals — in daily experience. Understanding the link between them will not solve chronic pain, but it may meaningfully reduce it for a significant number of people currently suffering without a clear biological explanation for why.

That, in itself, is worth far more than a moment in the sunshine.

✦

Sources & References

1. European Medical Journal. Vitamin D Deficiency and Chronic Widespread Pain. EMJ Reviews. emjreviews.com
2. Xie Y, Farrell SF, Armfield N, Sterling M. Serum Vitamin D and Chronic Musculoskeletal Pain: A Cross-Sectional Study of 349,221 Adults in the UK. The Journal of Pain. 2024;25(9):104557. ScienceDirect
3. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clinic Proceedings. 2003;78(12):1463–70.
4. PMC. Prevalence and risk factors of vitamin D deficiency among patients with chronic myofascial pain syndrome. PMC10647172. pmc.ncbi.nlm.nih.gov
5. Habib AM et al. Vitamin D and Its Potential Interplay With Pain Signaling Pathways. Frontiers in Immunology. 2020;11:820. Frontiers
6. PMC. Does Vitamin D Affect Diabetic Neuropathic Pain and Balance? PMC6970609. pmc.ncbi.nlm.nih.gov
7. PMC. Vitamin D3 Attenuates Neuropathic Pain via Suppression of Mitochondria-Associated Ferroptosis. PMC11427799. PubMed Central
8. Bayer TA et al. Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses. Translational Psychiatry. 2024. Nature
9. Nutrients. Does Vitamin D Supplementation Impact Fibromyalgia-Related Pain? A Systematic Review and Meta-Analysis. 2025;17(20):3232. MDPI
10. Chen YC et al. Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2023;15(13):2830. PubMed Central
11. PMC. Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PMC12554626. PubMed Central
12. Hao S et al. Association between serum vitamin D and severe headache or migraine: A population-based analysis. PLOS ONE. 2025;20(1):e0313082. PLOS ONE
13. Nutrients. Vitamin D in the Transition from Acute to Chronic Pain: A Systematic Review. 2025;17(11):1912. MDPI
14. Soens MA, Sesso HD, Manson JE et al. The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITAL trial. Pain. 2024;165:635–43.
15. Cui A et al. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Frontiers in Nutrition. 2023. PubMed Central
16. PMC. Baseline Vitamin D Levels on Quality of Life and Pain Perception Among Patients with Chronic Pain with Long-Term Prescription Opioid Use. PMC11766184. PubMed Central

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any changes to your health regimen. World At Net does not endorse any specific treatment or supplement protocol.